CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.3195
+0.0020 (0.63%)
May 6, 2026, 3:41 PM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $408.82 million as of May 6, 2026. Its market cap has increased by 46.45% in one year.
Market Cap
408.82M
Enterprise Value
421.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.32
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 408.82M, an increase of 7,282.65%. That is a compound annual growth rate of 23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 408.82M | 14.96% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 342.30M |
| Silence Therapeutics | 337.25M |
| Vaxart | 182.08M |
| Glorywin Entertainment Group | 149.60M |
| HST Global | 140.02M |
| NDT Pharmaceuticals | 114.12M |
| BioStem Technologies | 74.11M |
| Nuo Therapeutics | 58.08M |